Professor Carmel Hawley
Professor

Carmel Hawley

Email: 

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Clinical sciences

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Search Professor Carmel Hawley’s works on UQ eSpace

721 works between 1965 and 2025
All (721) Journal Article (490) Conference Publication (225) Book Chapter (6)

561 - 580 of 721 works

2008

Conference Publication

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell .

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

2008

Conference Publication

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

Kaisar, M., Armstrong, K., Prins, J., Marwick, T., Johnson, D., Hawley, C. and Isbel, N. (2008). The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell.

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS

Wilson, S., Van Epps, C., Hawley, C., Blagg, C. R. and Agar, J. W. M. (2007). COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS. HOBOKEN: WILEY-BLACKWELL.

COMPARING THE RELATIVE SURVIVAL ADVANTAGE BY STANDARDIZED MORTALITY RATIO OF AN AUSTRALIAN NHHD COHORT AND A MATCHED CONVENTIONAL HD COHORT FROM USRDS

2007

Conference Publication

PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION

Campbell, S., Hawley, C., Irish, A., Hutchison, B., Walker, R. and Ferrari, P. (2007). PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION. HOBOKEN: WILEY-BLACKWELL.

PRE-TRANSPLANT PHARMACOKINETICS AS A PREDICTOR OF DOSE REQUIREMENT POST RENAL TRANSPLANTATION

2007

Conference Publication

ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE

Tong, A., Sainsbury, P., Harris, D., Walker, R., Hawley, C., Chadban, S., Hall, B., Carter, S. and Craig, J. C. (2007). ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE. HOBOKEN: WILEY-BLACKWELL.

ELICITING PRIORITIES FOR RESEARCH FROM PATIENTS WITH CHRONIC KIDNEY DISEASE

2007

Journal Article

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

Johnson, David W., Armstrong, Kirsten, Campbell, Scott B., Mudge, David W., Hawley, Carmel M., Coombes, Jeff S., Prins, Johannes B. and Isbel, Nicole M. (2007). Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology, 12 (4), 391-398. doi: 10.1111/j.1440-1797.2007.00804.x

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

2007

Journal Article

Is it time to revisit residual renal function in haemodialysis?

Ng, Tsun G., Johnson, David W. and Hawley, Carmel M. (2007). Is it time to revisit residual renal function in haemodialysis?. Nephrology, 12 (3), 209-217. doi: 10.1111/j.1440-1797.2007.00795.x

Is it time to revisit residual renal function in haemodialysis?

2007

Journal Article

Check program on chronic kidney disease

Johnson, D. W., Hawley, C. M. and Mathew, T. (2007). Check program on chronic kidney disease. Check, Unit 423

Check program on chronic kidney disease

2007

Journal Article

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

Wiggins, Kathryn J., Rumpsfeld, Markus, Hawley, Carmel M., O'Shea, Amanda, Isbel, Nicole M., Campbell, Scott B. and Johnson, David W. (2007). Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology, 12 (3), 218-223. doi: 10.1111/j.1440-1797.2006.00702.x

Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

Live donor characteristics over the last 15 years

Kaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Live donor characteristics over the last 15 years

2007

Conference Publication

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell Publishing.

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

2007

Conference Publication

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD). 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

2007

Conference Publication

Follow-up of 15 years of live donors in a large Australian renal transplant unit

Kaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Follow-up of 15 years of live donors in a large Australian renal transplant unit

2007

Conference Publication

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

2007

Journal Article

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

Craven, Ann-Maree S., Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G. and Johnson, David W. (2007). Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis. Peritoneal Dialysis International, 27 (2), 184-191. doi: 10.1177/089686080702700216

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

2007

Conference Publication

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

Kaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Conference Publication

Adverse outcomes in alternate nightly home nocturnal haemodialysis

van Eps, Carolyn, Jeffries, Janine, Isbel, Nicole, Johnson, David, Campbell, Scott, Mudge, David and Hawley, Carmel (2007). Adverse outcomes in alternate nightly home nocturnal haemodialysis. 44th ERA-EDTA Congress, Barcelona, Spain, 22-24 June 2007 . Oxford, United Kingdom: Oxford University Press.

Adverse outcomes in alternate nightly home nocturnal haemodialysis

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2012
    A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease
    The Roche Foundation for Anemia Research
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Availability

Professor Carmel Hawley is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au